{"id":203540,"name":"BIOREFERENCE LABORATORIES AN OPKO HEALTH COMPANY","slug":"bioreference-laboratories-an-opko-health-company","state":"NJ","country":"United States of America","description":"Clinical Laboratory","totalSpending":1027000,"filings":26,"yearlySpending":[{"year":2019,"income":175000},{"year":2020,"income":210000},{"year":2021,"income":200000},{"year":2022,"income":250000},{"year":2023,"income":100000},{"year":2024,"income":92000}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["JD LISS ASSOCIATES FORMERLY KNOWN AS JONATHAN DAVID LISS"],"lobbyists":["JONATHAN LISS"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","White House Office","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Laboratory Payment\nLaboratory Regulation\nMedicare/Medicaid\nHealth Information Technology","HR 3107-Prior authorization for payment for genetic testing\n\nRegulation of clinical laboratory testing\n\nPayment for clinical lab testing/PAMA","Regulation of clinical laboratory testing\n\nPayment for laboratory testing\n\nPrior authorization for genetic testing","HR 3107-Prior authorization for payment for genetic testing\n\nRegulation of clinical laboratory testing\n\nPayment for clinical lab testing/PAMA","HR 3107-Prior authorization for payment for genetic testing\n\nRegulation of clinical laboratory testing\n\nPayment for clinical lab testing/PAMA"]}